acceptodds
Published as a conference paper at NeurIPS 2026

SafeDrug: A Benchmark Dataset for Safety-Critical Pharmacological Reasoning in LLMs

Tengfei Ma, Yushan Yang, HOU Jiahao, Yujie Chen, Guanghui Ye, Xuanbai Ren, Yiping Liu, Bosheng Song, xiangxiang Zeng

Abstract

Large language models (LLMs) have shown strong performance on biomedical tasks, yet evaluating their reasoning in safety-critical pharmacological contexts requires large-scale, structured datasets. We present SafeDrug, a benchmark dataset for systematic evaluation of pharmacological reasoning across multiple task dimensions. SafeDrug integrates heterogeneous sources, including adverse drug event records, drug–drug interaction knowledge, literature-derived evidence, and population-specific information such as child, adult, and older adult groups, into a unified reasoning-oriented QA format. The benchmark comprises two complementary subsets. SafeDrug-large provides broad coverage at scale, while SafeDrug-small is a high-quality human-annotated subset for precise evaluation. It supports tasks such as prediction, risk assessment, mechanism explanation, evidence-grounded QA, and drug replacement across both single-drug and multi-drug settings. Our evaluation shows that LLMs capture outcome-level associations but struggle with mechanistic reasoning, evidence alignment, and population-aware predictions. SafeDrug provides a foundation for reproducible benchmarking and advances research on evidence-grounded and population-aware pharmacological reasoning in LLMs.

Related papers

See more related submissions when the market opens.